Introduction. Genistein (plant isoflavone) is a well-known anti-cancer drug with estrogenic-like properties. Genistein also regulates sugar and lipid metabolism; thus, it has anti-diabetic properties. The aim of the study was to evaluate in vitro effects of genistein on glucose transport, fatty acids oxidation, activation of PKB, and expression of genes related to insulin pathway in differentiated myoblast C2C12 mouse cell line. Material and methods. Differentiated myoblast C2C12 mouse cell line was used to assess the effects of different genistein concentrations on glucose transport and fatty acids oxidation measured by radioactivity technique, activation of PKB, and expression of selected genes related to insulin signaling pathway (IR-a, IR-b, IRS-1, PKB, GLUT-4, PP2A, SH-PTP2) at the mRNA and protein levels. Cells were incubated with various concentrations of genistein under standard conditions for 0-48 hours. Results. Genistein in low concentrations (0.1-1 µM) significantly increased glucose transport and decreased fatty acids oxidation in C2C12 cells after 48 h of incubation. High concentration of genistein (50 µM) had the opposite effect. Genistein stimulated PKB phosphorylation during the first 5-10 minutes of incubation. There 124 Slawomir Lewicki et al.
Introduction
Genistein (4',5,7-trihydroxyisoflavone) is a phytoestrogen found in plants from Fabaceae family such as soybeans. It has numerous health benefits, such as positive regulation of homeostasis, attributed to its multiple biological functions [1] . The concentration of genistein in human and animal body fluids depends on the type of diet. A human diet rich in vegetable products (including soybean and soybean-derived products) significantly increases concentration of this phytoestrogen in the body [2] .
Multiple studies suggest that dietary phytoestrogens play a beneficial role in reducing obesity and protecting against diabetes, as well as in improving glucose metabolism and insulin resistance [3] . In cells, the glucose level is regulated by insulin, the major hormone controlling critical cellular energy functions. The glucose and lipid metabolism is regulated by activation and regulation of the insulin cellular pathway-associated genes including receptors and related proteins, i.e. insulin receptors (IRs), insulin receptor substrate 1 (IRS-1), phosphoinositide 3-kinase (PI-3K) and protein kinase B (PKB) [4] . Perturbations of this pathway lead to development of type 2 diabetes that manifests by increased chronic insulin resistance and the loss of function of pancreatic b-cells. Because of the growing incidence of type 2 diabetes and complications related to this widespread disease, the identification of effective drugs protecting b-cells functions is extremely important [5] . Genistein is one of the drugs with such a potential [6] .
Many studies have demonstrated that genistein has a direct anti-diabetic effect after administration to animals and humans [7] . It increases b-cell proliferation and regeneration [8] , regulates glucose-stimulated insulin secretion (GSIS) [9] and protects cells against apoptosis [10] . These effects may be independent of genistein functions as an estrogen receptor agonist, antioxidant, or tyrosine kinase inhibitor [11, 12] . Genistein regulates a plethora of molecular pathways critical for cell homeostasis and survival. It affected i.e. activation of NF-kB pathway, PI3K/Akt/mTOR signaling pathway or MAPK/ERK pathway [13] . In low concertation (up to 10 µM) genistein induces cell proliferation, studied mainly in cancer cell lines (i.e. human breast cancer cell line MCF-7) [14] or human uterine leiomyoma [15] ). Higher concertation of genistein (above 10 µM) significantly reduced proliferation of many cell types (adipocytes 3T3 L1 [16] , muscle -RASMCs [17] , endothelial cells -HCAEC [18] or epithelial cell line RWPE-1 [19] ) and induced apoptosis [20] .
The aim of the present study was to investigate the effects of genistein on energy metabolism, gene transcription profile and the expression of proteins related to the insulin pathway. Experiments were carried out on mouse myoblast cell line C2C12, because these cells exhibit strong reactivity to the modification of glucose metabolism.
Materials and methods
The work was approved by institutional review boards and the State Committee for Scientific Research (KBN, Poland).
Cell culture. Experiments were performed in vitro on mouse C2C12 myogenic cell line obtained from the European Collection of Animal Cell Cultures (Porton Down, UK). Cells were grown in Dulbecco Modified Eagle's Medium (DMEM) supplemented with 20% fetal bovine serum (FBS), antibiotics: penicillin-streptomycin (50 IU/mL) and fungizone (2.5 µg/mL) (all purchased from Life Technologies, Warsaw, Poland) in an atmosphere of 5% CO 2 /95% humidified air at 37°C. Confluent culture (about 90% of confluence) was differentiated in DMEM containing 2% of horse serum (Life Technologies) for three days. On the 3 rd day, medium was removed and cells were washed twice with phosphate buffered saline (PBS, Life Technologies, Warsaw, Poland). DMEM without serum was added for the next 24 h. Then the cells were washed twice with PBS and the experiments were commenced.
Genistein. Genistein was purchased from SigmaAldrich (Poznan, Poland). The stock solution was dissolved in ethanol (99.8%, SigmaAldrich). The working solutions were stored at -80°C. [21] and the radioactivity of the remaining sample was analyzed in a liquid scintillation counter (Packard TRI-CARB, Packard, Ramsey, MN, USA). Results are presented as % of control value (mean ± SD) from 4 independent experiments.
Measurement of fatty acids oxidation. Level of b-oxidation was analyzed according to Manning et al. [22] . The experiment was performed on cells cultured in 24-well plate. Genistein (0-control, 0.1; 1 or 50 µM) was added to the medium (DMEM without FBS) for 1, 3, 6 and 48 hours. After given time of incubation medium was removed, cells were rinsed twice with PBS and incubated with tritium labeled [9, H] palmitic acid (radioactivity 280.1 Bq, Amersham, UK) in PBS. After 60 min of incubation (37°C, 5% CO 2 , 95% humidity) cells were washed twice with PBS. Then 200 µl of 2 M NaOH was added. Following incubation for 24 h cells were lysed. A fifty µl of the lysates were used for protein assay [21] and the remaining samples were transferred to AG-1-X8 column (Bio-Rad, Munich, Germany). The column filtrate was analyzed in a liquid scintillation counter (Packard TRI-CARB). The activity of b-oxidation in C2C12 cells was determined by the amount of tritiated water formed from the oxidation of ([9,10- Western blot. The experiment was performed on cells cultured in 6-well plates. After genistein treatment (0, 0.1, 1 or 50 µM) total proteins were extracted from cells using RIPA buffer (Sigma Aldrich) and centrifuged at 2000 g for 20 min. Protein extracts were separated in 4-12% denaturing polyacrylamide gel. Proteins were blotted onto nitrocellulose membrane (Life Technologies, Warsaw, Poland) and blocked with 5% fat-free dry milk in Tris-buffered saline Tween (TBST, Sigma Aldrich) at 4°C. After washing with TBST, proteins were incubated overnight at 4°C with primary antibodies (Santa Cruz Biotechnology, Heidelberg, Germany): rabbit polyclonal IgG anti-p(ser437)Akt-1/2/3, rabbit polyclonal IgG anti-Akt 1/2/3, rabbit polyclonal IgG anti-IRa and b, rabbit polyclonal IgG SH-PTP2, rabbit polyclonal IgG anti-PP2A-Ca, rabbit polyclonal IgG anti-GAPDH, rabbit polyclonal IgG anti-IRS1, rabbit polyclonal IgG anti-ERa and chicken polyclonal IgG anti-ERb503 received from Prof. Jan-Åke Gustafsson and Dr. Margaret Warner from the Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden. The bound antibodies were detected by second peroxidase-conjugated antibodies: donkey polyclonal IgG anti-rabbit HRP and rabbit polyclonal IgG anti-chicken HRP (Santa Cruz Biotechnology) and chemiluminescence (ECL detection reagent; Amersham). For densitometry analysis X-Ray films were scanned, and integrated optical density (IOD) was measured using Kodak 1D 3.5 software (New Haven, CT, USA). The densitometric values of the investigated proteins were normalized to GAPDH (glyceraldehyde-3-phosphate dehydrogenase). All western blots analyzes were performed at least in triplicate. Results are presented as % of control value (mean ± SD).
Microarray analysis.
Microarray analysis was performed using SuperArray kit (Bio-Rad, Munich, Germany). Genistein (1 µM) was added for 4 h (short stimulation) or 24 h (long stimulation) to cells cultured as described above. RNA extraction, cRNA and cDNA synthesis and hybridization were performed according to the manufacture's protocols. Hybridization results were visualized on X-ray plates, scanned (CanoScan Lide 60, Ōta, Tokio, Japan), and analyzed in GEArray Expression Analysis Suite (SuperArray software, available on the manufacturer's website SABiosciences Corp., Frederick, MD, USA). The densitometry values of the investigated genes were normalized to GAPDH, rps27a (ribosomal protein S27a) and b2m (b-2 microglobulin), hsp90ab1 (heat shock protein 90 kDa a -cytosolic, class B member 1) and ppia (peptidylprolyl isomerase A). Based on this study we compiled the list of genes which expression was changed at least 100% comparing to the control values.
Statistical analysis. The significance of the difference was assessed by parametric t-test for a normal distribution of values and Kruskal-Wallis test for a non-parametric distribution of values (GraphPad Prism 4 software, La Jolla, CA, USA). P values < 0.05 were considered significant.
Results

Glucose transport in differentiated myoblast C2C12 cell line
We examined the effects of genistein (Gen) on the intracellular glucose transport. Genistein at 50 µM concentration, but not at lower concentrations, caused dramatic (~85%) reduction of glucose transport (p < 0.001) regardless of the incubation time ( (Fig. 1) . After 48 h of incubation these two concentrations caused a slight 10% (Gen 0.1 µM, p < 0.05; Gen 1 µM, p < 0.001) increase in glucose uptake (Fig. 1 ).
Fatty-acids b-oxidation in differentiated myoblast C2C12 cell line
We tested the effect of genistein on fatty acids oxidation. One-hour incubation of differentiated myoblast C2C12 cell line with 50 µM genistein increased b-oxidation by 34.4%, p < 0.001). This effect dissipated with time of incubation: 115.2% after 3 hours and 83.8% after 6 hours (Fig. 2) . After 48 h of incubation with genistein there was a dose-dependent reduction in the b-oxidation activity: 0.1 µM -73.9% (p < < 0.001), 1 µM -92.1% (p < 0.05) and 50 µM -97.8% (p > 0.05) relative to the control value (Fig. 2) .
Effects of genistein on insulin signaling pathways proteins
Protein kinase B (PKB) is one of the major proteins of the insulin pathway, which regulates cell response to the glucose level. One µM genistein caused a very rapid and significant increase (by 40%, p < 0.01) in the PKB kinase phosphorylation level during the first 15 min of incubation. This effect disappeared after 30 min of incubation (Fig. 3 ).
There were no significant changes in the expression level of the other studied insulin pathway proteins, i.e. insulin receptor IR-beta, IRS-1 or PKB kinase when cells were incubated with 0.1, 1 and 50 µM genistein (Suppl. Fig. 1A, C, D) . There was also no effect of genistein (0.1, 1 and 50 µM) on the expression of IR receptors (Suppl. Fig. 1A, B) , GLUT-4 (Suppl. Fig. 1E ) and estrogen receptors (ER-a and ER-b, Suppl. Results from western blot analysis revealed that genistein caused no change in the expression of the phosphatase PP2A-Ca. Only at 50 µM concentration, genistein increased PP2A-Ca expression by 20% after 48 h incubation (Suppl. Fig. 1H ). In contrast, there was a positive correlation between the genistein concentration and expression of SH2 protein tyrosine phosphatase 2 (SH-PTP2) (Suppl. Fig. 1I ).
Effects of genistein on gene expression pattern
Microarray analysis was focused on 119 genes related to insulin signaling pathway. The analysis of genes' expression in the control conditions after 4 and 24 h incubation of the differentiated myoblast C2C12 cell line with the genistein revealed only slight effects ( Table 1) . Addition of 1 µM genistein for 4 h caused increase in the expression of 21 genes, among which the 11 genes were activated by genistein (not detected in control condition, Table 2 ). Only one gene (nck1, Table 2 ) showed reduced expression. Genistein-affected genes belonged to the following families and pathways: insulin receptor family, PI-3 kinase pathway, MAPK kinase pathway, insulin pathway, carbohydrate metabolism, lipid metabolism, transcrip- Table 2 .
Disscusion
Comparison between populations of Asian and Western developed countries showed that a diet rich in phytoestrogens reduces the incidence of cardiovascular diseases and disorders of the carbohydrate and lipid metabolism [23] . Similar health effects were observed for a diet rich in soy-based foods; it caused www.fhc.viamedica.pl a decrease in total cholesterol, low-density lipoprotein (LDL) and triglycerides without modification of high-density lipoprotein (HDL) concentration in serum of postmenopausal women [24] . Studies on male CD-1 mice also confirmed positive effects of soy products on animal health. Soy-containing diet caused reduction in serum insulin level, pancreatic insulin content, AMP-activated protein kinase (AMPK) phosphorylation, activated expression of genes responsible for the fatty acids oxidation (in the adipose tissue) and increased glucose transport activity in muscle cells [25] . It has been shown in mice that soy-enhanced diet prevented obesity and related disorders [26] .
Genistein is one of the most active soy isoflavones. It is involved in the regulation of lipid and glucose metabolism, but the exact role, the mechanism of action and the degree of its positive health impact are poorly understood. Genistein is structurally similar to 17b-estradiol, which allows its binding to the estrogen receptors and the activation of protein kinase A (PKA) [27] . Our previous studies on differentiated myoblast C2C12 cell line showed that 10 nmol of 17 b-estradiol significantly affected the expression of genes related to the insulin pathway [28] . This study suggested that genistein might affect sugar and lipid metabolism through interactions with estrogen receptors. There are also reports indicating a non-estrogenic effect of genistein. The studies of Liu et al. [12] showed that genistein regulated the secretion of insulin in two insulin-secreting cell lines INS-1 and MIN6, through the signal cascade closely related to the cAMP activation. Genistein increased intracellular cAMP level and activated PKA by a mechanism unrelated to estrogen receptor or protein tyrosine kinase (PTK) but associated with the stimulation of adenylate cyclase activity.
It has been also suggested that genistein may modulate the activity of glucose transport at the cellular level. Our results obtained in the present studies are consistent with the results of Shuo-Bin et al. [29] studies on C2C12 cells. We showed that 50 µM genistein caused inhibition (approximately by 85%) of glucose uptake. We also showed that low doses of genistein had only slight but statistically significant effect on glucose transport in C2C12 cells (± 10% change) both after short (1-6 h) and long (48 h) incubation (Fig. 1) . Similar results were obtained by Nomura et al. [30] . In their studies the 1 h incubation with low concertation (1-5 µM) of genistein did not affect Involved in tyrosine phosphorylation of CBL by linking CBL to the insulin receptor; required for insulin-stimulated glucose transport; involved in formation of actin stress fibers and focal adhesions
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glucose uptake in mouse MC3T3-G2/PA6 cells differentiated into mature adipocytes. Higher concertation of genistein (10 µM) significantly decreased glucose uptake and this inhibitory effect was not reversed by addition of insulin. We also observed similar correlation; genistein at low concentration did not affect insulin-stimulated glucose uptake; however, at high concentration (50 µM) it inhibited insulin-stimulated glucose transport (our unpublished data). Nomura et al. [30] also showed that genistein (10 µM) had no effect on insulin-stimulated phosphorylation of PKB. Also Bazuine et al. [31] showed in 3T3-L1 adipocytes that the higher genistein concentration (above 20 µM) caused inhibition of glucose uptake, which was independent of protein kinase PKB inhibition. These authors concluded that genistein affected function of proteins such as the GLUT4 transporter and that, in 3T3-L1 adipocytes, genistein is a potent and direct inhibitor of GLUT-4 insulin-stimulated glucose uptake [31] . Another study showed that the effect of genistein in 3T3-L1 adipocytes was unrelated to insulin-stimulated GLUT4 translocation from the low-density microsomes to the plasma membrane [32] . Authors suggested that observed effect might be related to the decrease in the intrinsic activity of the glucose uptake by conformational change of GLUT-4 transporter. Interestingly, we found that high concentration of genistein (50 µM) adversely affected energy metabolism in C2C12 cells. It also enhanced fatty acids metabolism during a short-term period (1-3 hours) of incubation. This observation may explain a positive therapeutic effect of genistein on human obesity and diabetes [6] . We think that the inhibitory effect of 50 µM genistein on the glucose uptake can be related to the increased level of membrane phosphatase SH-PTP2 responsible for muting the signal from induced insulin receptor. This phosphatase may play a role in the inhibition of the glucose transport by genistein, because its cell content increased parallely to increased genistein concentration. In addition, some in vitro studies have demonstrated positive effects of genistein on glucose transport in the C2C12 cells (stimulation of about 100%, at concentrations from 0.01 to 100 µM) that was associated with the increased phosphorylation level of the insulin receptor substrate IRS-1 [29] . Genistein also increased the Akt phosphorylation level in aged rats, which may be related to the increase in the upstream interaction of ERb with p85a protein [6] . We observed that the C2C12 cells incubated with 0.1 µM genistein showed about 10% increase in glucose transport and 50% increase in the amount of GLUT4 protein at the cell membrane (data not showed). In contrast, the high concentration of genistein (50 µM) resulted in 85% decrease in C2C12 cells growth rate and reduction in the amount of GLUT4 protein at the cell membrane after insulin stimulation (15 min, 100 nM concentration). Also Wang et al. [1] showed that in adipoyctes (3T3-L1 cells) genistein had antiglycemic properties associated with the activation of AMPK and induction of GLUT4 translocation to the cell membrane.
Our results demonstrated that 1 µM genistein rises PKB kinase activity by about 40% as compared to the control, but only during the first 10 to 15 min of incubation. The observed effect was not associated with the increase in glucose transport. The studies on mouse cell line MC3T3-G2/PA6 showed that 1 h incubation with 10 µM genistein has no effect on the inhibition of insulin-stimulated proteins phosphorylation: beta-IR, IRS-1 and Akt [30] . This suggests that the inhibition of glucose transport caused by genistein concentrations higher than 1 µM does not depend on the phosphorylation of insulin pathway kinases.
Our microarray studies showed no significant changes in the level of mRNAs of the above-described proteins associated with insulin signaling pathway. We observed that genistein treatment resulted in different gene expression activation profile than estradiol treatment and modulated the expression level of insulin pathway genes to the lower extent than estradiol [28] . This may suggest that genistein regulates the insulin pathway protein levels by different mode of action than estradiol. It is also of interest that the 24 hours incubation with 1 µM genistein reduced the mRNAs levels of glucokinase (GCK) and Sorbs1, and increased mRNA level of kinase Akt1. The Sorbs1 protein is related to the regulation of cell response to insulin and its mutation causes insulin resistance [33] . In turn, glucokinase regulates carbohydrate metabolism in response to rising or falling levels of glucose [34] . Moreover, it has been shown that genistein is a potent alpha-glucosidase inhibitor [35] .
In conclusion, genistein, depending on concentration, causes different biological effects in C2C12 cells. High concentrations strongly decreased glucose transport and cell proliferation as showed by us previously but did not affect b-oxidation of fatty acids. Results obtained in the present study indicate that genistein (at a low concertation of 1 µM) may modulate glucose and lipid metabolism by two independent modes of action. The first would be a direct stimulation of different cell receptors (i.e. Insulin-like Growth Factor receptor [36] or estrogen receptors [37, 38] ) -after short stimulation there is a time-dependent increase in PKB phosphorylation and the stimulation of fatty acids metabolism. The second mode, a long-term stimulatory effect, would be related to the modulation at the transcriptional level expression of genes associated with insulin signaling pathway. Further detailed studies on these two modes of regulation may help to develop genistein-based anti-obese and anti-diabetic therapies.
